Aimei Health Faces 60-Day Nasdaq Deadline After Late Q1 10-Q Filing Notice
AFJK•Aimei Health Technology Co. received a Nasdaq notice citing noncompliance for missing its May 15 deadline to file the Form 10-Q for quarter ended March 31, 2026. The company has 60 days to file the report or submit a compliance plan or face potential delisting under Listing Rule 5250(c)(1).
1. Nasdaq Notice Details
On May 19, 2026, Aimei Health Technology Co. received formal notification from Nasdaq for failing to file its Form 10-Q by the May 15 deadline for the quarter ended March 31, 2026, breaching Listing Rule 5250(c)(1). The notice does not immediately affect trading but flags a deficiency in listing qualifications.
2. Compliance Timeline and Consequences
Under Nasdaq rules, the company has 60 calendar days to either file the delayed report or submit a remedial plan. If the plan is accepted, Aimei may be granted up to 180 days from the original due date to regain compliance; otherwise, its securities could be subject to delisting, though an appeal to a hearings panel is available.
